LUMN vs NBIX · rev $5.70B vs P/E 45, rev $1.77B
Lumen Technologies Inc (LUMN) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Lumen Technologies Inc (LUMN) is a telecom services company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported LUMN revenue for 2026-06-30 was $5.70B. Net income was -$401.0M. Revenue was up 96.8% from 2026-03-31 to 2026-06-30. LUMN currently screens at market cap $4.72B.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
LUMN currently screens at market cap $4.72B. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the LUMN and NBIX stock pages for the full models.
Not investment advice.